Warburg Effect

The Warburg Effect is a metabolic phenomenon characterized by the preference of cancer cells for aerobic glycolysis over oxidative phosphorylation, even when oxygen is plentiful (Warburg, 1956, Science). This metabolic shift results in high glucose uptake and the rapid conversion of glucose to lactate, providing the carbon skeletons and NADPH necessary for biomass synthesis and cell proliferation (Vander Heiden et al., 2009, Science). While the Warburg Effect itself is a complex biological process rather than a single molecular target like a receptor or enzyme, it is considered a fundamental hallmark of cancer and a framework for therapeutic development (NCI Dictionary of Cancer Terms). Drugs designed to exploit this effect typically target specific rate-limiting enzymes such as Hexokinase 2 or Lactate Dehydrogenase A, or transporters like MCT1, to starve the tumor or disrupt its pH regulation. Clinical application of this effect is most notably seen in diagnostic imaging using 18F-FDG PET scans, which visualize the abnormally high glucose consumption of malignant tissues. However, targeting this pathway presents significant challenges, as many normal tissues, including the brain and red blood cells, are also heavily dependent on glucose metabolism for survival.

Other names

Aerobic glycolysisWarburg metabolismMetabolic reprogrammingGlycolytic switch

Inhibition of the Warburg Effect is achieved by targeting its constituent components, such as inhibiting glucose transporters (GLUT), glycolytic enzymes (Hexokinase, LDH-A, PKM2), or monocarboxylate transporters (MCT1/4) to disrupt energy production and lactate export in cancer cells (Liberti & Locasale, 2016, Trends Biochem Sci).